For the year ending 2025-12-31, BBNX has $328,743K in assets. $41,133K in debts. $31,576K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 31,576 | |||
| Restricted cash, current | 100 | |||
| Short-term investments | 187,549 | |||
| Accounts receivable, net | 17,118 | |||
| Inventories, net | 21,722 | |||
| Prepaid expenses and other current assets | 9,840 | |||
| Total current assets | 267,905 | |||
| Total cost | 14,355 | |||
| Less accumulated depreciation and amortization | 5,755 | |||
| Property and equipment, net | 8,600 | |||
| Operating lease right-of-use asset | 6,627 | |||
| Long-term investments | 45,431 | |||
| Other long-term assets | 180 | |||
| Total assets | 328,743 | |||
| Accounts payable | 4,998 | |||
| Accrued expenses and other current liabilities | 22,431 | |||
| Operating lease liabilities | 1,938 | |||
| Deferred revenue | 1,557 | |||
| Total current liabilities | 30,924 | |||
| Operating lease liabilities, net of current portion | 5,365 | |||
| Deferred revenue, net of current portion | 3,297 | |||
| Other long-term liabilities | 1,547 | |||
| Total liabilities | 41,133 | |||
| Preferred stock | 0 | |||
| Common stock | 4 | |||
| Additional paid-in capital | 657,140 | |||
| Accumulated other comprehensive income | 403 | |||
| Accumulated deficit | -369,937 | |||
| Total stockholders' equity (deficit) | 287,610 | |||
| Total liabilities, convertible preferred stock and stockholders' equity (deficit) | 328,743 | |||
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)